of atrial fibrillation
safe, easy, and effective
WHO WE ARE
ElectroPhysiology Frontiers is a MedTech company that has developed an innovative, easy to use “single-shot” catheter ablation system to provide durable ablations and reduce the rate of recurrence of Atrial Fibrillation (AFib) after pulmonary vein isolation (PVI).
The journey of ElectroPhysiology Frontiers began in 2019 when the company was formed by TechWald Holding S.p.A.
EPF later received additional investments to further assist us in advancing our mission.